Drug Type CAR-T |
Synonyms TMMSTN02 |
Target |
Action inhibitors |
Mechanism MSLN inhibitors(Mesothelin inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | United States | - | |
Mesothelioma | Preclinical | United States | - | |
Ovarian Epithelial Carcinoma | Preclinical | United States | - | |
Pancreatic Cancer | Preclinical | United States | - |